-
A Study In Adults With Moderate To Severe Dermatomyositis
Scottsdale/Phoenix, AZ
A Study looking at Investigational drug and Placebo administered to adult Patients with moderate to severe Dermatomyositis
-
A Phase 3 Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN
The purpose of this study is to determine the effetiveness and safety of brepocitinib (a tyrosine kinase [TYK] 2/Janus kinase [JAK] 1 inhibitor) in patients with dermatomyositis.
-
A Study to Evaluate the Effectiveness, Safety and Tolerability of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis
Jacksonville, FL
The purpose of this study is to evaluate the investigational drug PF-06823859 and a placebo administered to adult pPatients with moderate-to- severe Dermatomyositis.
-
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
Scottsdale/Phoenix, AZ; Jacksonville, FL
The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.
-
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Scottsdale/Phoenix, AZ; Jacksonville, FL
what is the efficacy of lenabasum compared to placebo in subjects with dermatomyositis (DM) as measured by TotalImprovement Score (TIS)
-
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Rochester, MN
The purpose of this multi-center pilot study is to determine if the drug tocilizumab (Actemra) is effective in the treatment of patients with refractory adult polymyositis (PM) and dermatomyositis (DM).
-
Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
Rochester, MN
Prospective, Double-blind, Randomized, Placebo-Controlled Phase III Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis ("ProDERM study")